Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-throughput genomic and proteomic analysis using microarray technology.

J X Huang1, D Mehrens, R Wiese

  • 1Genometrix Inc., 2700 Research Forest Dr., The Woodlands, TX 77381, USA.

Clinical Chemistry
|September 25, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
Same journal

In Reply to Reflexing NT-proBNP for sFlt-1/PlGF Ratios That Fall into the Measurement Uncertainty for Preeclampsia Risk Classification.

Clinical chemistry·2026
See all related articles

This study introduces an adaptable microarray technology for high-throughput screening of genes and proteins. It enables rapid analysis of thousands of patient samples for disease risk and drug response discovery.

Area of Science:

  • Biotechnology
  • Genomics
  • Proteomics

Background:

  • High-density microarrays excel at analyzing thousands of genes in limited samples.
  • Further screening of candidate genes in extensive patient cohorts is crucial for disease research.

Purpose of the Study:

  • To develop and validate a versatile microarray platform for high-throughput genetic and protein analysis.
  • To enable rapid screening of numerous patient samples for disease association studies.

Main Methods:

  • Utilized a microarray platform for both single-nucleotide polymorphism (SNP) genotyping and protein expression analysis.
  • Employed customizable microarrays in 16- or 96-format slides, accommodating 4,000-24,000 elements for parallel sample processing.

Main Results:

Related Experiment Videos

  • SNP genotyping results on the microarray platform showed full agreement with traditional methods like sequencing and RFLP analysis.
  • Protein profiling via multiplexed microarrays demonstrated high correlation coefficients (0.82-0.99) compared to ELISA.

Conclusions:

  • The integrated microarray technology platform is adaptable and versatile.
  • It provides essential high-throughput capabilities for drug development and discovery.